UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Effect of Carvedilol on Exercise Performance in Fontan Patients

Phase 4

Completed

Conditions: Single Ventricle
Fontan

Interventions: Drug: Carvedilol
Drug: Placebo

First Posted Date: 2016-10-27

Last Posted Date: 2021-01-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 26

Registration Number: NCT02946892

Locations: 🇺🇸
University of Texas Southwestern, Dallas, Texas, United States

Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System

Not Applicable

Completed

Conditions: Breast Cancer
Colorectal Cancer

Interventions: Other: Care Coordination Strategies

First Posted Date: 2016-10-24

Last Posted Date: 2024-03-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 4322

Registration Number: NCT02943265

Locations: 🇺🇸
UT Southwestern Medical Center Department of Population and Data Sciences, Dallas, Texas, United States

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

Phase 1

Completed

Conditions: Non-Small Cell Lung Carcinoma

Interventions: Drug: BGB324
Drug: Docetaxel

First Posted Date: 2016-10-04

Last Posted Date: 2024-02-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 23

Registration Number: NCT02922777

Locations: 🇺🇸
Covenant Health Systems/Joe Arrington Cancer Treatment and Research Center, Lubbock, Texas, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Dallas 2K: A Natural History Study of Depression

Recruiting

Conditions: Depression, Bipolar
Depression

Interventions: Other: Observational Study

First Posted Date: 2016-09-29

Last Posted Date: 2024-05-28

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 2000

Registration Number: NCT02919280

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

Phase 3

Completed

Conditions: Alcoholism
Bipolar Disorder
Alcohol Abuse

Interventions: Drug: Placebo
Drug: Aripiprazole

First Posted Date: 2016-09-28

Last Posted Date: 2023-08-02

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 132

Registration Number: NCT02918370

Locations: 🇺🇸
UT Southwestern, Dallas, Texas, United States

A Clinical Trial of Patients With Melanoma

Phase 1

Withdrawn

Conditions: Melanoma

Interventions: Drug: Digoxin Combination
Drug: Dabrafenib
Drug: Trametinib

First Posted Date: 2016-09-27

Last Posted Date: 2018-05-15

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT02915666

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Risk Reduction for Alzheimer's Disease

Phase 2

Completed

Conditions: Cognitively Normal Older Adults
Hypertension
Subjective Cognitive Decline
Family History of Alzheimer's Disease

Interventions: Behavioral: Aerobic Exercise Training
Drug: Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
Other: Usual Care
Behavioral: Stretching Exercise

First Posted Date: 2016-09-26

Last Posted Date: 2022-02-15

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 513

Registration Number: NCT02913664

Locations: 🇺🇸
University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

and more 1 locations

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Phase 1

Terminated

Conditions: Cancer of Pancreas

Interventions: Drug: Nintedanib

First Posted Date: 2016-09-15

Last Posted Date: 2024-06-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 14

Registration Number: NCT02902484

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

High Dose Rate Brachyablation of Primary Liver Lesions

Phase 1

Terminated

Conditions: Liver Cancer

Interventions: Radiation: brachytherapy

First Posted Date: 2016-09-09

Last Posted Date: 2021-05-18

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 1

Registration Number: NCT02893982

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Extra Sitting Time After Spinal Anesthesia for Cesarean Section and Fetal Well-being

Not Applicable

Withdrawn

Conditions: Complications; Cesarean Section
Hypotension

Interventions: Other: Various sitting time

First Posted Date: 2016-09-08

Last Posted Date: 2019-01-31

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT02893696

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy